1. Home
  2. PMTS vs MGTX Comparison

PMTS vs MGTX Comparison

Compare PMTS & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CPI Card Group Inc.

PMTS

CPI Card Group Inc.

SELL

Current Price

$25.11

Market Cap

300.1M

Sector

Finance

ML Signal

SELL

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

SELL

Current Price

$8.73

Market Cap

881.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PMTS
MGTX
Founded
2007
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
300.1M
881.7M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
PMTS
MGTX
Price
$25.11
$8.73
Analyst Decision
Strong Buy
Buy
Analyst Count
4
8
Target Price
★ $33.50
$27.75
AVG Volume (30 Days)
146.8K
★ 588.9K
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.02
EPS
★ 0.76
0.68
Revenue
★ $312,189,000.00
$81,391,000.00
Revenue This Year
$12.30
$309.55
Revenue Next Year
$8.71
N/A
P/E Ratio
$32.96
★ $13.62
Revenue Growth
12.27
★ 144.57
52 Week Low
$10.81
$6.62
52 Week High
$31.25
$15.35

Technical Indicators

Market Signals
Indicator
PMTS
MGTX
Relative Strength Index (RSI) 48.78 39.64
Support Level $23.34 $6.99
Resistance Level $25.74 $10.08
Average True Range (ATR) 1.88 0.53
MACD -0.06 0.05
Stochastic Oscillator 39.09 19.35

Price Performance

Historical Comparison
PMTS
MGTX

About PMTS CPI Card Group Inc.

CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit segment, which principally produce secure debit and credit cards and provide card services for U.S. card-issuing financial institutions, including personalization, instant issuance and other payment solutions such as digital push provisioning for mobile wallets; Prepaid Debit, which provides secure packaging solutions, Prepaid Debit Cards, and other integrated prepaid card services to prepaid program managers in the U.S.; and other: principally corporate expenses. The firm generates key revenue from Debit and Credit segment.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: